title: Pharmacovigilance for plasma-derived clotting factor concentrates.
authors.forename: G
authors.initials: G
authors.lastname: Tagariello
authors.forename: F
authors.initials: F
authors.lastname: Cavallin
authors.forename: P G
authors.initials: PG
authors.lastname: Davoli
authors.forename: G B
authors.initials: GB
authors.lastname: Gajo
authors.forename: E
authors.initials: E
authors.lastname: De Biasi
authors.forename: A
authors.initials: A
authors.lastname: Traldi
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D001779:Blood Coagulation Factors / Q000009:adverse effects / Q000627:therapeutic use*; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans
chemical_list: D001779:Blood Coagulation Factors